Bridgewater Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Bridgewater Associates's QGEN Position: Q1 2025 in Review
Bridgewater Associates sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 5,663 shares — an estimated $259K sold.
Bridgewater Associates first reported a position in QGEN in Q2 2021 and held it in 11 quarters. The position peaked at $8.24M in Q1 2023. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.
- Bridgewater Associates reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
- Bridgewater Associates sold 5,663 Qiagen shares in Q1 2025, an estimated $259K.
- Bridgewater Associates first reported a position in Qiagen in Q2 2021 and held it in 11 quarters.
- Bridgewater Associates's Qiagen position peaked at $8.24M in Q1 2023.
- 298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.
Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.